Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Jupiter Wellness, Inc. JUPWW NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • USD

SharesGrow Score
31/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Jupiter Wellness, Inc. (JUPWW) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.32. It has a SharesGrow Score of 29/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $4M, +203.1%/yr average growth. Net income is $68M (loss), growing at -88.2%/yr. Net profit margin is -1735.2% (negative). Gross margin is 31.5% (+14.9 pp trend).

Balance sheet: total debt is $347,754 against $35M equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 1.01 (adequate). Debt-to-assets is 0.8%. Total assets: $41M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 36/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

JUPWW SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 36/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — JUPWW

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
JUPWW: +203.1%/yr revenue is, -88.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet JUPWW: Debt-to-Equity (D/E) ratio 0.01 (conservative), Current ratio is 1.01 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
36/100
JUPWW: Gross margin is 31.5% (+14.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 36/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
JUPWW: Net profit margin is -1735.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.2703-0.47
Volume6.82K
Beta (1Y)1.64
Share Statistics
EPS (TTM)-15.88
Shares Outstanding$4.29M
Financial Highlights & Ratios
Revenue (TTM)$3.93M
Gross Profit$1.24M
EBITDA$-66.94M
Net Income$-68.19M
Operating Income$-34.49M
Total Cash$2.39M
Total Debt$347.75K
Net Debt$-1.93M
Total Assets$40.97M
Price / Earnings (P/E)-0
Analyst Forecast
Company Info
ExchangeNASDAQ Capital Marke
CurrencyUSD

Price Chart

Track all markets on TradingView
JUPWW
Jupiter Wellness, Inc.  ·  NASDAQ Capital Marke
Healthcare • Drug Manufacturers - Specialty & Generic
0.27 52WK RANGE 0.47

People Also View

JUPW
JUPW
Jupiter Wellness, Inc.
$1.52
+11.76%
 KERNW
KERNW
Akerna Corp.
$0.00
+5.26%
 IMTXW
IMTXW
immatics biotechnologies GmbH
$0.00
-88.46%
 GMBLW
GMBLW
Esports Entertainment Group, Inc.
$0.04
+2,368.75%
 BCDAW
BCDAW
BioCardia, Inc.
$0.01
-3.17%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message